Literature DB >> 10735952

The clinical spectrum of epidermolysis bullosa simplex.

H M Horn1, M J Tidman.   

Abstract

As part of the U.K. National Epidermolysis Bullosa Register, we have systematically recorded clinical information on 130 (77%) of the 168 known Scottish epidermolysis bullosa simplex (EBS) sufferers. Three subtypes of EBS were recognized: Dowling-Meara (EBS-DM), Weber-Cockayne (EBS-WC) and Köbner (EBS-Kb), seen in 5%, 42% and 53% of patients, respectively. As there is considerable overlap between EBS-WC and EBS-Kb, with both phenotypes frequently seen within the same pedigree, EBS-WC is best regarded as a milder variant of EBS-Kb rather than a separate disorder. Improvement with age is common in all variants of EBS, but is not invariable. Pain due to acral blistering in EBS-Kb/EBS-WC has a more marked impact on life-style than the blisters of EBS-DM. Oral blistering, nail involvement and aplasia cutis congenita occur in all EBS subtypes and laryngeal involvement is a feature of EBS-DM. Seasonal variation is not seen in EBS-DM but is common in EBS-Kb/EBS-WC.

Entities:  

Mesh:

Year:  2000        PMID: 10735952     DOI: 10.1046/j.1365-2133.2000.03358.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

Review 1.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

2.  A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.

Authors:  Jodi Y So; Shivali Fulchand; Christine Y Wong; Shufeng Li; Jaron Nazaroff; Emily S Gorell; Mark P de Souza; Dedee F Murrell; Joyce M Teng; Albert S Chiou; Jean Y Tang
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

3.  Bart's syndrome.

Authors:  Aruna Rajpal; R Mishra; K Hajirnis; M Shah; N Nagpur
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 4.  Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility.

Authors:  Pierre A Coulombe; Michelle L Kerns; Elaine Fuchs
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

5.  Novel keratin 5 mutation in a family with epidermolysis bullosa simplex.

Authors:  Jiajia Gao; Xuebin Wang; Fang Zheng; Sufang Dong; Xueping Qiu
Journal:  Exp Ther Med       Date:  2015-10-16       Impact factor: 2.447

Review 6.  Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath.

Authors:  Pierre A Coulombe; Chang-Hun Lee
Journal:  J Invest Dermatol       Date:  2012-01-26       Impact factor: 8.551

7.  The use of cultured allogenic keratinocyte grafting in a patient with epidermolysis bullosa simplex.

Authors:  Kee Cheol Shin; Bo Young Park; Han Koo Kim; Woo Seob Kim; Tae Hui Bae
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

8.  Severe Generalized Epidermolysis Bullosa Simplex in Two Hong Kong Children due to De Novo Variants in KRT14 and KRT5.

Authors:  Shuk Ching Chong; Kam Lun Hon; Fernando Scaglia; Chung Mo Chow; Yu Ming Fu; Tor Wo Chiu; Alexander K C Leung
Journal:  Case Rep Pediatr       Date:  2020-04-17

9.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11

10.  Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.

Authors:  Thomas Kocher; Patricia Peking; Alfred Klausegger; Eva Maria Murauer; Josefina Piñón Hofbauer; Verena Wally; Thomas Lettner; Stefan Hainzl; Michael Ablinger; Johann Wolfgang Bauer; Julia Reichelt; Ulrich Koller
Journal:  Mol Ther       Date:  2017-08-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.